SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as market participants react to recent news indicating efforts to significantly lower mortgage rates, which is broadly seen as a major catalyst for the housing market. The community is highly bullish, anticipating a potential short squeeze and strong upside as improved affordability could drive increased transaction volume for real estate platforms.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as its innovative Optical Interposer technology gains significant validation, notably following Marvell's acquisition of partner Celestial AI, underscoring its pivotal role in next-generation AI and data center optical interconnects. The community is buzzing about POET's patented, high-speed, and energy-efficient solutions, which are critical for scaling AI infrastructure beyond copper's limitations. Speculation is high for major upcoming orders and a substantial revenue ramp, positioning the company as a key player in the photonics sector.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending amid intense debate following a recent filing regarding convertible note conversions, which the company frames as a debt reduction. The community is sharply divided, with many fearing significant dilution from newly registered shares, while a strong bullish contingent anticipates a short squeeze, citing high cost to borrow and the stock's history of extreme volatility and parabolic price movements.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Federal National Mortgage Association (FNMA) is trending amidst heightened speculation about its future, fueled by recent commentary from prominent figures regarding potential government-directed mortgage bond purchases and its substantial cash reserves. The community is actively discussing these developments as signals for the long-anticipated privatization, including a potential uplisting or IPO, which could significantly impact the housing market and mortgage rates. Noted investors are also expressing bullish sentiment, further intensifying the conversation around the mortgage giant's path out of conservatorship.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors react sharply to disappointing preliminary Q4 results and conservative long-term revenue guidance for DefenCath, particularly concerning post-TDAPA reimbursement. While some view the drop as an overreaction to a known payment cliff, many in the community are voicing strong criticism of management's strategic decisions and recent acquisitions. Hope for recovery now hinges on upcoming pipeline catalysts like REZZAYO and potential support from the Kidney Care Access Protection Act.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is generating buzz around its participation at CES 2026, where it is highlighting advancements in agentic voice AI for vehicles and smart devices, including a new partnership with TomTom. The community is actively discussing the company's strong revenue growth, significant contractual backlog, and substantial short interest, leading to both optimism for a potential breakout and frustration over perceived market manipulation suppressing its stock price.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Crypto is gaining significant attention as its dedicated "Wolfpack" community rallies around the recent launch of WolfSwap, a cross-chain aggregator, and eagerly anticipates a groundbreaking flagship utility. The community remains highly bullish, driven by continuous building and a vision to usher in a new era for memecoins, emphasizing decentralized growth and utility.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies is gaining significant attention following news regarding proposed governmental action aimed at boosting the housing market and lowering mortgage rates. The community anticipates a substantial refinancing and home-buying boom, viewing RKT's integrated platform and scale as perfectly positioned to capitalize on these sector-wide tailwinds. Many express strong long-term optimism, seeing potential for significant upside as the market re-rates the company amidst a normalizing mortgage cycle and its enhanced ecosystem.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following a high-profile social media post from former President Trump, praising the company's CEO, government investment, and new sub-2nm CPU processor. This has fueled widespread community discussion around Intel's renewed technological competitiveness with its 18A process and Core Ultra Series 3 chips for AI PCs, driving optimism for a significant turnaround despite some skepticism about sustained momentum.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Andrew Callos Sells 15,000 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 15,000 shares of Cytokinetics stock in a transaction on Monday, January 5th. The shares were sold at an average price...

Cytokinetics (NASDAQ:CYTK) EVP Sells $904,200.00 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 15,000 shares of Cytokinetics stock in a transaction dated Monday, January 5th. The shares were sold at an average...

Cytokinetics (NASDAQ:CYTK) EVP Sells $112,590.76 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,798 shares of the firm's stock in a transaction dated Friday, January 2nd. The shares were sold at an average price...

Moody Aldrich Partners LLC Buys Shares of 82,460 Cytokinetics, Incorporated $CYTK

Moody Aldrich Partners LLC purchased a new position in Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and...

Cytokinetics (NASDAQ:CYTK) Trading 3% Higher - Still a Buy?

Cytokinetics (NASDAQ:CYTK) Trading 3% Higher - Time to Buy...

Insider Selling: Cytokinetics (NASDAQ:CYTK) EVP Sells 1,809 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,809 shares of the stock in a transaction on Monday, December 29th. The shares were sold at an average price of...

Cytokinetics (NASDAQ:CYTK) EVP Andrew Callos Sells 1,809 Shares of Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Andrew Callos sold 1,809 shares of Cytokinetics stock in a transaction on Monday, December 29th. The stock was sold at an average price...

What Does the Market Think About Cytokinetics Inc?

Cytokinetics FY2025 EPS Forecast Reduced by HC Wainwright

Cytokinetics, Incorporated (NASDAQ:CYTK - Free Report) - Equities researchers at HC Wainwright cut their FY2025 earnings estimates for shares of Cytokinetics in a research note issued to investors on...

Wendell Wierenga Sells 20,000 Shares of Cytokinetics (NASDAQ:CYTK) Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) Director Wendell Wierenga sold 20,000 shares of Cytokinetics stock in a transaction on Monday, December 22nd. The stock was sold at an...

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

Current Price	$63.32
Prev Close	$65.42
Open	$65.35
Dividend Yield	0.00%
50-Day Moving Average	$63.50
Beta	0.95
Avg. Volume	2.07M
PE Ratio	-10.37

52-Week High	$70.98
52-Week Low	$29.31
Market Capitalization	$8B
EPS (Annual)	-$5.26
Price to Book	-15.33
Revenue Per Employee	$37,096.39
Enterprise Value/EBITDA	N/A

CYTK
Cytokinetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CYTK News

CYTKCytokinetics Inc